Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Institute for Health and Care Excellence
Pharma
NICE rejects Vertex, CRISPR's Casgevy, asks for more data
In its draft guidance, the U.K.'s cost watchdog recognized the need for the sickle cell therapy but needs more data from Vertex on its effectiveness.
Zoey Becker
Mar 14, 2024 11:24am
NICE rejects cost effectiveness of Vertex's cystic fibrosis meds
Nov 6, 2023 2:42pm
Lilly's Mounjaro bags key coverage recommendation in England
Sep 8, 2023 8:17am
Grifols opens plant, snags NICE nod for Tavlesse
Oct 19, 2022 10:15am
